SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-259461
Filing Date
2021-08-27
Accepted
2021-08-27 17:06:09
Documents
13
Period of Report
2021-08-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d222503d8k.htm   iXBRL 8-K 25607
2 EX-10.1 d222503dex101.htm EX-10.1 48583
  Complete submission text file 0001193125-21-259461.txt   213741

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lhdx-20210823.xsd EX-101.SCH 2904
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lhdx-20210823_lab.xml EX-101.LAB 18123
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lhdx-20210823_pre.xml EX-101.PRE 11413
6 EXTRACTED XBRL INSTANCE DOCUMENT d222503d8k_htm.xml XML 3346
Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address 1412 62ND STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Filer) CIK: 0001652724 (see all company filings)

IRS No.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39976 | Film No.: 211219990
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences